WuXi Global Forum 2023


Dear Colleagues and Friends,

Now in its 11th year, the WuXi Global Forum will resume in person on January 10th, 2023 in San Francisco during the 2023 J.P. Morgan Healthcare Conference. Global leaders and innovators will once again convene to catalyze new thinking on this global stage as we strive to advance breakthroughs faster for patients.

We welcome you to join the conversations. Please click HERE to reserve your complimentary on-site event pass.

Distinguished Guest Speakers for WuXi Global Forum 2023 (partial list):

Christiana Bardon, Co-Managing Partner of BioImpact Capital, an MPM affiliate

Tom Barnes, CEO, Orna Therapeutics

Niranjan Bose, Managing Director, Health & Life Sciences, Gates Ventures

Ros Deegan, CEO, OMass Therapeutics

Giulio Draetta, SVP & CSO, MD Anderson Cancer Center

Ken Drazan, Chairman, CEO, Co-Founder, ArsenalBio

Juergen Eckhardt, SVP & Head of Leaps by Bayer

C. Simone Fishburn, VP & Editor in Chief, BioCentury Inc.

Todd Golub, Director, Broad Institute of MIT & Harvard

Keith Gottesdiener, President & CEO, Prime Medicine

Stephen Hauser, Director, UCSF Weill Institute for Neurosciences; Professor, Department of Neurology, University of California, San Francisco

Sofia Ioannidou, Partner, Andera Partners

Mathai Mammen, Executive Vice President of R&D, Johnson & Johnson Pharmaceuticals (in transition)

John Mendlein, Executive Partner, Flagship Pioneering

John Ngai, Director, NIH BRAIN Initiative

Dan Nomura, Professor of Chemical Biology and Molecular Therapeutics, University of California, Berkeley

Vijay Pande, General Partner, Andreessen Horowitz

Michal Preminger, Regional Head, Johnson & Johnson Innovation East North America

Nancy Pryer, CSO, Ambagon Therapeutics

Aviv Regev, Head, Genentech Research and Early Development

Michael Severino, CEO, Tessera Therapeutics; CEO-Partner, Flagship Pioneering

Laura Shawver, President & CEO, Capstan Therapeutics

Catherine Stehman-Breen, CEO, Chroma Medicine

Lance Stewart, Chief Strategy and Operations Officer, Institute for Protein Design, University of Washington

Romesh Subramanian, CEO, Ascidian Therapeutics

Carol Suh, Partner, ARCH Venture Partners

Sze-Wee Tan, Assistant Chief Executive, Innovation and Enterprise Group, Singapore Agency for Science, Technology and Research (A*STAR)

Michelle Werner, CEO, Alltrna; CEO-Partner, Flagship Pioneering

Joseph Wu, Professor & Director, Stanford Cardiovascular Institute; Co-founder & SAB, Greenstone Biosciences

Register Now

Subscribe to WXPress

Receive our newsletter and information on upcoming events.